Authors:
MALFERTHEINER P
MEGRAUD F
OMORAIN C
BELL D
BIANCHI PG
DELTENRE M
FORMAN D
GASBARRINI G
JAUP B
MISIEWICZ G
PAJARES J
QUINA M
RAUWS E
ANDERSEN L
ARENAS MI
BAZZOLI F
BERSTAD A
BIANCHI P
BIRKNER B
BRUN J
BUCKLEY M
BURES J
BUTRUK E
CADRANEL S
CASAS RJ
CASPARY F
COTTRILL M
CULHANE A
DEKOSTER E
DITE P
FARKKILA M
FUJIOKA T
FUKUDA T
GLUPCZYNSKI Y
HIRSCHL A
HUNT R
JOHANNESSEN T
KREJS G
LABENZ J
LAMERS C
LIND T
MCCOLL K
NUESCH H
ODONOGHUE D
OFFER G
PEURA D
POMBAL R
POUNDER R
PRETOLANI P
ROKKAS T
ROMAOZINHO J
RUNE S
SANDELOWSKY H
SEIFERT B
SHIMOYAMA T
SJOLUND K
STOCKBRUGGER R
THOMSON A
UBALDI E
UNGE P
VANCUTSEM E
WADSTROM T
WEBER J
SIPPONEN P
PRICE A
Citation: P. Malfertheiner et al., CURRENT EUROPEAN CONCEPTS IN THE MANAGEMENT OF HELICOBACTER-PYLORI INFECTION - THE MAASTRICHT CONSENSUS REPORT, Gut, 41(1), 1997, pp. 8-13
Authors:
LIND T
MEGRAUD F
BARDHAN KD
BAYERDORFFER E
HELLBLOM M
OMORAIN C
SPILLER RC
UNGE P
VANZANTEN SJOV
WRANGSTADH M
ZEIJLON L
CEDERBERG C
Citation: T. Lind et al., THE MACH2 STUDY - ANTIMICROBIAL RESISTANCE IN HELICOBACTER-PYLORI THERAPY - THE IMPACT OF OMEPRAZOLE, Gut, 41, 1997, pp. 89-89
Authors:
MALFERTHEINER P
BAYERDORFFER E
DIETE U
GIL J
LIND T
MISIUNA P
OMORAIN C
SIPPONEN P
SPILLER RC
STASIEWICZ J
TREICHEL HC
UJSZASZY L
UNGE P
VANZANTEN SJOV
ZEIJLON L
Citation: P. Malfertheiner et al., THE GU-MACH STUDY - ERADICATION OF HELICOBACTER-PYLORI, ULCER HEALINGAND RELAPSE IN GASTRIC-ULCER PATIENTS - OMEPRAZOLE AND CLARITHROMYCININ COMBINATION WITH EITHER AMOXICILLIN OR METRONIDAZOLE, Gut, 41, 1997, pp. 97-97
Authors:
VANZANTEN SJOV
BRADETTE M
FARLEY A
BAYERDORFFER E
LIND T
OMORAIN C
SIPPONEN P
SPILLER RC
UNGE P
SINCLAIR P
WRANGSTADH M
ZEIJLON L
Citation: Sjov. Vanzanten et al., THE DU-MACH STUDY - ERADICATION OF HELICOBACTER-PYLORI, ULCER HEALINGAND RELAPSE IN DUODENAL-ULCER PATIENTS - OMEPRAZOLE AND CLARITHROMYCIN IN COMBINATION WITH EITHER AMOXICILLIN OR METRONIDAZOLE, Gut, 41, 1997, pp. 103-103
Authors:
LIND T
BARDHAN KD
BAYERDORFFER E
HELLBLOM M
OMORAIN C
SPILLER RC
UNGE P
VANZANTEN SV
WRANGSTADH M
ZEIJLON L
Citation: T. Lind et al., THE MACH-2 STUDY - OPTIMAL HELICOBACTER-PYLORI THERAPY NEEDS OMEPRAZOLE AND CAN BE RELIABLY ASSESSED BY UBT, Gastroenterology, 112(4), 1997, pp. 200-200
Authors:
MEGRAUD F
LEHN N
LIND T
BAYERDORFFER E
OMORAIN C
SPILLER RC
UNGE P
VANZANTEN SV
WRANGSTADH M
BURMAN CF
Citation: F. Megraud et al., THE MACH-2 STUDY - HELICOBACTER-PYLORI RESISTANCE TO ANTIMICROBIAL AGENTS AND ITS INFLUENCE ON CLINICAL OUTCOME, Gastroenterology, 112(4), 1997, pp. 216-216
Authors:
EKSTROM P
CARLING L
WETTERHUS S
WINGREN PE
ANKERHANSEN O
LUNDEGARDH G
THORHALLSSON E
UNGE P
Citation: P. Ekstrom et al., PREVENTION OF PEPTIC-ULCER AND DYSPEPTIC SYMPTOMS WITH OMEPRAZOLE IN PATIENTS RECEIVING CONTINUOUS NONSTEROIDAL ANTIINFLAMMATORY DRUG-THERAPY - A NORDIC MULTICENTER STUDY, Scandinavian journal of gastroenterology, 31(8), 1996, pp. 753-758
Citation: P. Unge et A. Berstad, POOLED ANALYSIS OF ANTI-HELICOBACTER PYLORI TREATMENT REGIMENS, Scandinavian journal of gastroenterology, 31, 1996, pp. 27-40
Authors:
MALFERTHEINER P
BORSCH G
SOLCIA E
BELL GD
JONSSON B
UNGE P
BRUN J
AXON ATR
BAZZOLI F
LEE A
MEGRAUD F
Citation: P. Malfertheiner et al., MANAGEMENT OF HELICOBACTER-PYLORI-POSITIVE PEPTIC-ULCER DISEASE - DISCUSSION .4., Scandinavian journal of gastroenterology, 31, 1996, pp. 119-121
Authors:
LAURITSEN K
AALYKKE C
HAVELUND T
KNUDSEN T
GLISE H
UNGE P
EKSTROM P
JAUP B
NORRBY A
STUBBEROD A
MELEN K
BOLLING E
JERNDAL P
JUNGHARD O
Citation: K. Lauritsen et al., EFFECT OF OMEPRAZOLE IN FUNCTIONAL DYSPEPSIA - A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY, Gastroenterology, 110(4), 1996, pp. 702-702
Citation: P. Unge et al., THE COST-EFFECTIVENESS OF HELICOBACTER-PYLORI ERADICATION VERSUS MAINTENANCE AND EPISODIC TREATMENT IN DUODENAL-ULCER PATIENTS IN SWEDEN, PharmacoEconomics, 8(5), 1995, pp. 410-427
Authors:
LIND T
VANZANTEN SJO
UNGE P
SPILLER RC
BAYERDORFFER E
OMORAIN C
WRANGSTADH M
IDSTROM JP
Citation: T. Lind et al., THE MACH-1 STUDY - OPTIMAL ONE-WEEK TREATMENT FOR HELICOBACTER-PYLORIDEFINED, Irish medical journal, 88(5), 1995, pp. 166-166
Authors:
EKSTROM P
CARLING L
UNGE P
ANKERHANSEN O
SJOSTEDT S
SELLSTROM H
Citation: P. Ekstrom et al., LANSOPRAZOLE VERSUS OMEPRAZOLE IN ACTIVE DUODENAL-ULCER - A DOUBLE-BLIND, RANDOMIZED, COMPARATIVE-STUDY, Scandinavian journal of gastroenterology, 30(3), 1995, pp. 210-215
Authors:
BACK S
CARLING L
EKSTROM P
GLISE H
IDSTROM JP
HELLBLOM M
STROM M
UNGE P
WEYWADT L
WRANGSTADH M
Citation: S. Back et al., ERADICATION OF HELICOBACTER-PYLORI WITH EITHER PHENOXYMETHYLPENICILLIN, BENZYLPENICILLIN OR AMOXICILLIN IN COMBINATION WITH OMEPRAZOLE - A SWEDISH MULTICENTER STUDY, Gastroenterology, 108(4), 1995, pp. 50-50
Authors:
BAILEY RJ
MARLICZ K
ROSCH W
DEMUCKADELL S
SCHULZ T
THJODLEIFSSON B
UNGE P
ROBERTS PM
Citation: Rj. Bailey et al., GR122311X (RANITIDINE BISMUTH CITRATE) A NEW DRUG FOR THE TREATMENT OF GASTRIC-ULCER, Gastroenterology, 108(4), 1995, pp. 51-51
Citation: A. Gad et P. Unge, ANTIBACTERIAL THERAPY OF HELICOBACTER-PYLORI-ASSOCIATED PEPTIC-ULCER DISEASE - A NEW STRATEGY - THE SWEDES GO FOR IT, Journal of clinical gastroenterology, 19(1), 1994, pp. 6-10
Citation: P. Unge et No. Stalhammar, THE COST-EFFECTIVENESS OF HELICOBACTER-PYLORI ERADICATION VS MAINTENANCE TREATMENT IN DUODENAL-ULCER PATIENTS - THE CASE OF SWEDEN, Gastroenterology, 106(4), 1994, pp. 10000032-10000032